Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy

Background: Sudden cardiac death (SCD) is a common cause of death in hypertrophic cardiomyopathy (HCM), but identification of patients at a high risk of SCD is challenging. The study aimed to validate the three SCD risk stratifications recommended by the 2011 ACCF/AHA guideline, the 2014 ESC guideli...

Full description

Bibliographic Details
Main Authors: Yan Dong, Wen Yang, Chongchong Chen, Jiamei Ji, Wei Zheng, Fengxiang Zhang, Bing Yang, Xiaorong Li, Xiujuan Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
hypertrophic cardiomyopathy
sudden cardiac death
risk stratification
guideline
Chinese patients
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.691653/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.691653/full

Similar Items